logo
[breadcrumb_custom]

Tag: Lineage Cell Therapeutics Inc.

Finance

LCTX’s Market Whiplash: 7.34% YTD Rise, 3.54% Rise in 30 Days

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant gain of 7.34% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -12.69%. Over the past 30 days, the price of LCTX has fallen by 3.54%. And in the last five days, it has fallen by -9.30%. Lineage Cell Therapeutics Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $1.57 on 06/16/23,

News

LCTX Stock Update: Lineage Cell Therapeutics Inc’s Banking’s Market Struggles and Potential Opportunities

Lineage Cell Therapeutics Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $1.57 on 06/16/23, while the lowest value for the same period was recorded at $0.84 on 02/01/24. 52-week price history of LCTX Stock Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Lineage Cell Therapeutics Inc’s current trading price is -12.04% away from its 52-week high, while its distance from the 52-week low is 64.02%. The stock’s price range during the 52-week period has remained

Stock

Lineage Cell Therapeutics Inc: Rising -27.98% from 52-Week Low, Can the Stock Stay Afloat?

In terms of market performance, Lineage Cell Therapeutics Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $1.57 on 06/16/23, while the lowest value was $0.84 on 02/01/24. 52-week price history of LCTX Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Lineage Cell Therapeutics Inc’s current trading price is -27.98% away from its 52-week high, while its distance from the 52-week low is 34.30%. The stock’s price range for this period has

TOST Stock
News

Lineage Cell Therapeutics Inc (LCTX) Stock: The Story of a 52-Week Stock Range

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Lineage Cell Therapeutics Inc’s current trading price is -37.54% away from its 52-week high, while its distance from the 52-week low is 16.47%. The stock’s price range during this period has varied between $0.84 and $1.57. The company, active in the Healthcare sector, saw a trading volume of around 0.68 million for the day, considerably lower average daily volume of 0.7 million observed over the last three months. Lineage Cell Therapeutics Inc had a pretty

News

Lineage Cell Therapeutics Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio

Lineage Cell Therapeutics Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $1.57 on 06/16/23, and the lowest price during that time was $0.90, recorded on 12/15/23. 52-week price history of LCTX Stock A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Lineage Cell Therapeutics Inc’s current trading price is -36.27% away from its 52-week high, while its distance from the 52-week low is 11.04%. The stock’s price range during this period has fluctuated between $0.90 and $1.57. Shares of the company,